The Prohibited List

As an athlete or athlete support personnel, it is very important that you are familiar with the WADA Prohibited List and know how to check whether the medication you plan to take is prohibited or permitted. Remember that athletes are solely responsible for what they ingest or use.

The Prohibited list is set by WADA and is updated at least annually. It includes both substances and methods and it is categorized into 3 groups:

Substances and methods prohibited at all times
Substances and methods prohibited in-competition
Substances prohibited in particular sports

A substance or method can be added to the Prohibited List if it meets two of the following three criteria:

It has the potential to enhance or enhances sport performance.
Use of the substance or method represents an actual or potential health risk to the athlete.
Use of the substance or method violates the spirit of sport.

The Prohibited List is a comprehensive yet complicated document. Here are a few tips and tricks to help athletes and athlete support personnel navigate it:

Not everything on the Prohibited List is a medicine
Not every prohibited medicine is listed
Other substances with similar chemical structure or effect can also be prohibited
Only the ingredient names are listed, not brand names
Check the route of administration of the medicine
Check male or female use
Check dose restrictions
Many natural products are not specifically listed
Regularly check for updates to the Prohibited List

Both prescriptions and over-the-counter medications should be checked against the Prohibited List. Athletes should also inform their doctors of their obligations as high-performance athletes. In addition, it is important not to substitute one brand of medication for another without checking – they may contain different ingredients. Finally, the same brand or type of a medication may have different medical ingredients in another country – extra caution is recommended while travelling!

We recommend to use Global DRO to check all your medications. The Global Drug Reference Online (Global DRO) provides athletes and support personnel with information about the prohibited status of specific medications based on the current World Anti-Doping Agency (WADA) Prohibited List.

Supplements

Extreme caution is recommended regarding supplement use. Many countries do not follow strict rules in the manufacturing and labelling of supplements which may lead to a supplement containing a substance that is prohibited under anti-doping regulations. A significant number of positive tests have been attributed to the misuse of supplements and poorly labelled dietary supplements.

Before taking any supplements, you should weigh the benefits of their use against the risks. If you do decide to use supplements as part of your training and competition regime, check out the ITA supplement guide article first.

THERAPEUTIC USE EXEMPTIONS (TUEs)

1.What Is A Therapeutic Use Exemption (TUE)?

Athletes may have illnesses or conditions that require them to take medications or undergo procedures. If the medication or method an athlete is required to use to treat an illness or condition is prohibited as per the World Anti-Doping Agency’s (WADA) Prohibited List a TUE may give that athlete the authorization to use that substance or method while competing without invoking an anti-doping rule violation (ADRV) and applicable sanction. Applications for TUEs are evaluated by a panel of physicians, the TUE Committee (TUEC).

2.What are the Criteria for Granting a TUE?

All of the four following criteria must be met (for more details, please refer to the WADA International Standard for Therapeutic Use Exemptions (ISTUE) Article 4.2):

The athlete has a clear diagnosed medical condition which requires treatment using a prohibited substance or method;
The therapeutic use of the substance will not, on the balance of probabilities produce significant enhancement of performance beyond the athlete’s normal state of health;
The prohibited substance or method is an indicated treatment for the medical condition, and there is no reasonable permitted therapeutic alternative;
The necessity to use that substance or method is not a consequence of the prior use (without a TUE), of a substance or method which was prohibited at the time of use.

3.Who Should Apply for a TUE? Where and When to Apply?

The INTERNATIONAL FEDERATION OF TEQBALL (FITEQ) has delegated responsibility for all TUE applications to the International Testing Agency (ITA). This means that the ITA is now fully responsible for the TUE application process for all international-level athletes that fall under FITEQ’s jurisdiction.

Athletes who are subject to anti-doping rules would need a TUE to take a prohibited substance or use a prohibited method. You should verify with the ITA to know to whom you need to apply and if you can apply retroactively.

First, check if the required medication or method you intend to take, or use is prohibited as per the Prohibited List.

You may also use a ‘check your medication’ online like globalDRO (https://globaldro.com) or ask your NADO if it has one.

You have a responsibility to inform your physician(s) that you are an Athlete bound to anti-doping rules. You and your physician(s) should check the Prohibited List for the substance/method you are prescribed. If the substance/method is prohibited, discuss non-prohibited alternatives, if there are none, apply for a TUE. Remember Athletes have the ultimate responsibility. Contact your NADO or the ITA if you are having difficulties in assessing the status of a substance.

Then, verify below your status, to determine your competition level and TUE application requirements:

International Level Definition

Athletes included in the FITEQ Registered Testing Pool, Testing Pool and any Other Pool established by FITEQ.
Athletes who are ranked in the top 32 in each at the start of each season, where each season begins at the start of the calendar year on 01 January.

ª If it is determined that you are an International-Level Athlete you must apply to the ITA in advance, as soon as the need arises, unless there are emergency or exceptional circumstances.

For substances prohibited in-competition only, you should apply for a TUE at least 30 days before your next competition, unless one of the exceptions on retroactive TUEs (see below) apply.

Please refer to the section “How to apply to the ITA for a TUE?” below.

If you already have a TUE granted by your National Anti-Doping Organization (NADO):

ITA’s TUEC will automatically recognize it for purposes of international-level Competition without the need to review the relevant clinical information.

ª If you are NOT an International-Level Athlete and you have been tested by FITEQ, ITA’s TUEC recognizes a valid TUE granted by your NADO (i.e., it satisfies the ISTUE criteria for granting a TUE); unless you are required to apply for recognition of the TUE because you are competing in an international event.

If you are NOT a National-Level Athlete as defined by your NADO and you have been tested by FITEQ, you must apply for a retroactive TUE to the ITA.

4.Can I Get a Retroactive TUE?

You may only apply retroactively for a TUE to the ITA’s TUEC if:

You required emergency or urgent treatment of a medical condition.
There was insufficient time, opportunity or other exceptional circumstances that prevented you from submitting the TUE application, or having it evaluated, before getting tested.
You are a lower level athlete who is not under the jurisdiction of the IAF or NADO and were tested.
You tested positive after using a substance Out-of-Competition that is only prohibited In-Competition (for example glucocorticoids).

In rare and exceptional circumstances and notwithstanding any other provision in the ISTUE, you may apply for and be granted retroactive approval for a therapeutic use of a prohibited substance or method, if considering the purpose of the Code, it would be manifestly unfair not to grant a retroactive TUE.

This unique retroactive TUE will only be granted with the prior approval of WADA (and WADA may in its absolute discretion agree with or reject the ITA’s TUEC decision).

Important note:

Using a prohibited substance or method without a TUE could result in an Anti-Doping Rule Violation.

In case an application for a retroactive TUE is necessary following sample collection, you are strongly advised to have a medical file prepared and ready to submit for evaluation.

5.How to apply to the ITA for a TUE?

FITEQ encourages to submit TUE applications via ADAMS, together with the required medical information. If you do not have an ADAMS account yet, please contact tue@ita.sport to have it set up.

Otherwise, please download the TUE Application Form (found on https://ita.sport/TUE), and once duly completed and signed, gather the required medical file and contact tue@ita.sport.

Your TUE application must be submitted in legible capital letters or typing.

The medical file must include:

A comprehensive medical history, including documentation from the original diagnosing physician(s) (where possible);
The results of all examinations, laboratory investigations and imaging studies relevant to the application.

Any costs incurred by the Athlete in making the TUE application and in supplementing it as required by the TUEC are the responsibility of the Athlete.

Any TUE application that is not complete or legible will not be dealt with and will be returned for completion and re-submission.

To assist you and your doctor in providing the correct medical documentation, we suggest consulting the WADA’s Checklists for TUE applications for guidance and support, and Medical Information to Support the Decisions of TUECs for guidance on specific common medical conditions, treatments, substances, etc.

Keep a complete copy of the TUE application form and all medical information submitted in support of your application, and proof that it has been sent.

6.How to SUBMIT A REQUEST FOR RECOGNITION OF MY NADO’S TUE to THE ITA?

ITA’s TUEC will automatically recognize your TUE for purposes of international-level Competition without the need to review the relevant clinical information. If the TUE is correctly entered in ADAMS, there is no need to contact us. Nevertheless, should you require a confirmation, you can submit your request to the ITA in writing quoting your ADAMS TUE reference number.

You can download your TUE certificate directly from ADAMS.

7.What happens at major events?

You must verify with the Major Event, what are its TUE requirements.

Before the Period of the Games

You should follow the normal process and submit new requests to your IF or NADO. Pre-existing TUEs will follow the recognition process provided they are entered in ADAMS.

During the Period of the Games.

All Athletes participating in a Major Event should visit the dedicated webpage that describes the process for each Event.

8. When will I receive a decision on my TUE application [OR REQUEST FOR RECOGNITION]?

The ITA’s TUEC must render a decision as soon as possible, and usually within 21 days from the date of receipt of the complete TUE application, or request for recognition, unless in exceptional circumstances.

9.WHAT if I need to renew my TUE?

Each TUE has a specific duration, at the end of which it expires automatically. Should you need to continue to use the prohibited substance or method, it is your responsibility to submit a new application for a TUE with updated medical information ahead of the expiry date, so that there is sufficient time for a decision to be made prior to the expiry of the current TUE.

Important note:

The presence (following sample collection), use, possession or administration of the prohibited substance or method must be consistent with the terms of your TUE. Therefore, if you require a materially different dosage, frequency, route or duration of administration, you should contact the ITA, as you may be required to apply for a new TUE. Some substances and dosages, e.g. insulin, are often modified during treatment and these possible fluctuations should be mentioned by the treating physician in the TUE application and would usually be accepted by the ITA’s TUEC.

10.WHAT IF MY FITEQ TUE APPLICATION IS DENIED?

A decision to deny a TUE application will include a written explanation of the reason(s) for the denial. If it is not clear to you, please contact the ITA to understand exactly why the TUE was denied. Sometimes, there may be a critical piece of information, diagnostic test, laboratory results missing, etc. In which case, you should re-apply to us.

You and/or your NADO may refer the matter to WADA for review no later than 21 days after notification of the ITA’s TUEC decision. You should send the same information that you submitted to us, and on which the decision to deny the TUE was based on, via a secure on-line method or by registered mail at:

WADA Medical Department
World Anti-Doping Agency

Stock Exchange Tower

800 Place Victoria (Suite 1700)

P.O. Box 120

Montreal (Quebec) H4Z 1B7

Canada

The email address to enquire and/or send the request for review is: medical@wada-ama.org

It should be noted that WADA is not obliged to proceed with a request for a review. In that case, you and/or your NADO may appeal to the Court of Arbitration for Sport (CAS).

11.WHAT IF MY nado’S TUE IS NOT RECOGNIZED BY FITEQ?

You and/or your NADO have 21 days from the date of decision to refer the matter to WADA for review. The email address to enquire and/or send the request for review is: medical@wada-ama.org. Alternatively, you may send to:

WADA Medical Department
World Anti-Doping Agency
Stock Exchange Tower

800 Place Victoria (Suite 1700)

P.O. Box 120

Montreal (Quebec) H4Z 1B7

Canada

The same information that was provided to your NADO should be submitted to WADA. Please use a secure on-line method unless sending by registered mail.

Pending WADA’s decision, your NADO TUE remains valid for national-level competition and out-of-competition testing only.

If the matter is not referred to WADA for review, your NADO must determine whether the original TUE that was granted should remain valid for national-level Competition and Out-of-Competition Testing.

12.Will my medical information be treated in a confidential manner?

All the information contained in a TUE application, including the supporting medical information and any other information related to the evaluation of your TUE request is kept strictly confidential and treated in accordance with the Athlete’s Declaration contained in the ADAMS TUE and in the TUE Application Form which can be found here. All members of the TUEC and any other authorized recipients of your TUE request and related information (as described in the Athlete’s Declaration) are subject to a professional or contractual confidentiality obligation.

Please review the terms of the Athlete’s Declaration carefully. In particular, note that should you wish to revoke the right of the ITA’s TUEC to obtain the information related to your TUE in accordance with the Athlete’s Declaration, your TUE application will be deemed withdrawn without approval [or recognition] being granted.

Your TUE request-related information will be retained by FITEQ, ITA’s TUEC and any other authorized recipients for no longer than necessary for the purposes stated in the Athlete’s Declaration, in accordance with the International Standard for the Protection of Privacy and Personal Information.

13.Contact information

For any further information and questions in relation to personal information practices, please contact the ITA at privacy@ita.sport or FITEQ at privacy@fiteq.org .

If you have a doubt as regards to which organization you should apply for a TUE, or as to the recognition process, or any other question about TUEs, please contact: tue@ita.sport.

14.Other useful links:

WADA International Standard for Therapeutic Use Exemptions (ISTUE)

WADA Q&A on Therapeutic Use Exemptions

WADA Checklists for TUE Applications

WADA Guidelines for the 2021 International Standard for Therapeutic Use Exemptions (ISTUE) version 2022

WADA Anti-Doping Education and Learning (ADEL)

Year / Month	Men's singles	Men's doubles	Mixed doubles
2025/5	210	457	455
2025/4	174	462	451
2025/3	207	502	470
2025/2	267	550	-
2025/1	-	577	-
2024/12	-	557	-
2024/11	-	586	-